INSM Insmed Incorporated - Common Stock
INSM Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
INSM Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
INSM Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 9 30,0%
- Kup 20 66,7%
- Trzymaj 1 3,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
22 analityków · 2026-08-18Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.06 | $-0.80 | 0.74% |
| 31 marca 2026 | $-0.76 | $-0.98 | 0.22% |
| 31 grudnia 2025 | $-1.54 | $-1.32 | -0.22% |
| 30 września 2025 | $-1.75 | $-1.37 | -0.38% |
| 30 czerwca 2025 | $-1.70 | $-1.32 | -0.38% |
| 31 marca 2025 | $-1.42 | $-1.36 | -0.06% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| RVMD | — | — | — | — | — | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | — |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | · | |
| Cost of Revenue | $123M | $86M | $66M | $55M | $44M | $40M | $24M | $2M | $0 | $0 | · | · | |
| Gross Profit | · | · | · | · | · | · | $112M | $7M | $0 | · | · | · | |
| R&D Expense | $771M | $598M | $571M | $398M | $273M | $181M | $132M | $145M | $110M | $123M | $74M | $56M | |
| SG&A Expense | $701M | $461M | $345M | $266M | $234M | $204M | $211M | $168M | $79M | $51M | $43M | $31M | |
| Operating Expenses | $1.85B | $1.24B | $1.01B | $703M | $564M | $430M | $372M | $317M | $189M | $173M | $117M | $87M | |
| Operating Income | $-1.25B | $-878M | $-710M | $-457M | $-375M | $-265M | $-235M | $-307M | $-189M | $-173M | $-117M | $-87M | |
| Interest Expense | $84M | $85M | $82M | $26M | $40M | $30M | $28M | $25M | $6M | $3M | $3M | $2M | |
| Other Non-op | $-2M | $29.0K | $2M | $-6M | $-3M | $405.0K | $-531.0K | $602.0K | $300.0K | $119.0K | $-33.0K | $141.0K | |
| Pretax Income | $-1.27B | $-910M | $-747M | $-480M | $-436M | $-293M | $-254M | $-324M | $-193M | $-176M | $-120M | $-90M | |
| Income Tax | $5M | $4M | $3M | $1M | $-2M | $1M | $777.0K | $201.0K | $-272.0K | $98.0K | $-2M | $-10M | |
| Net Income | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| EPS (Basic) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| Shares (Basic) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| Shares (Diluted) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| EBITDA | $-1.25B | $-878M | $-704M | $-452M | $-366M | $-256M | $-230M | $-304M | $-186M | $-171M | $-116M | · |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $555M | $482M | $1.07B | $717M | $533M | $487M | $495M | $381M | $163M | $283M | $159M | |
| Short-term Investments | $920M | $879M | $298M | $74M | $0 | · | · | · | · | · | · | · | |
| Receivables | $141M | $52M | $41M | $30M | $24M | $17M | $19M | $6M | $0 | · | · | · | |
| Inventory | $132M | $99M | $83M | $70M | $67M | $50M | $28M | $7M | $0 | · | · | · | |
| Prepaid Expense | $91M | $37M | $24M | $25M | $29M | $24M | $20M | $11M | $8M | $6M | $5M | $5M | |
| Current Assets | $1.79B | $1.62B | $929M | $1.27B | $837M | $623M | $555M | $519M | $389M | $168M | $288M | $165M | |
| PP&E (Net) | $103M | $80M | $65M | $56M | $53M | $54M | $60M | $23M | $12M | $10M | $8M | $8M | |
| PP&E (Gross) | $164M | $130M | $110M | $96M | $90M | $82M | $79M | $37M | $23M | $18M | $13M | $11M | |
| Accum. Depreciation | $61M | $50M | $45M | $39M | $37M | $28M | $19M | $14M | $11M | $8M | $5M | $3M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $0 | · | · | · | · | · | · | |
| Intangibles | $98M | $59M | $64M | $69M | $74M | $49M | $54M | $59M | $58M | · | · | · | |
| Total Assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Accounts Payable | $80M | $73M | $65M | $50M | $36M | $43M | $13M | $18M | $15M | $10M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | $61M | $38M | $40M | $38M | $17M | $17M | $11M | $10M | |
| Current Liabilities | $469M | $298M | $226M | $190M | $135M | $119M | $85M | $80M | $45M | $28M | $22M | $20M | |
| Capital Leases | $12M | $9M | $11M | $15M | $21M | $21M | $29M | · | · | · | · | · | |
| Other Non-current Liabilities | $6M | $499.0K | $3M | $9M | $20M | $9M | $11M | $0 | $765.0K | $693.0K | $572.0K | $23.0K | |
| Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833M | $520M | $481M | $396M | $101M | $83M | $45M | $45M | |
| Long-term Debt | $547M | $1.12B | $1.18B | $1.15B | $800M | $450M | $450M | $450M | $55M | $55M | $25M | $25M | |
| Total Debt | $541M | $1.10B | $1.16B | $1.13B | $567M | $356M | $336M | $317M | $56M | $55M | $25M | · | |
| Common Stock | $2M | $2M | $1M | $1M | $1M | $1M | $897.0K | $773.0K | $766.0K | $620.0K | $618.0K | $498.0K | |
| Paid-in Capital | $6.37B | $4.65B | $3.11B | $2.78B | $2.67B | $2.11B | $1.80B | $1.49B | $1.32B | $919M | $900M | $657M | |
| Retained Earnings | $-5.64B | $-4.36B | $-3.45B | $-2.70B | $-2.27B | $-1.83B | $-1.54B | $-1.28B | $-958M | $-765M | $-589M | $-471M | |
| AOCI | $1M | $-2M | $-745.0K | $756.0K | $968.0K | $193.0K | $-10.0K | $-9.0K | $-3.0K | $-65.0K | · | · | |
| Stockholders' Equity | $739M | $285M | $-332M | $88M | $410M | $276M | $262M | $208M | $361M | $154M | $312M | $186M | |
| Liabilities + Equity | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Shares Outstanding | 214,255,853 | 179,383,000 | 147,978,000 | 135,654,000 | 118,738,000 | 102,763,060 | 89,682,387 | 77,307,521 | 76,610,508 | 62,019,889 | 61,813,995 | 49,806,131 |
Przepływy pieniężne 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $6M | $5M | $9M | $9M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Stock-based Comp | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | |
| Deferred Tax | $-27.0K | $-29.0K | $-54.0K | $-231.0K | $-3M | $0 | $0 | $0 | $-417.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $0 | $0 | · | · | |
| Other Non-cash | · | · | $133M | $18M | $20M | $29M | $-28M | $36M | $12M | $9M | $-89.0K | · | |
| Operating Cash Flow | $-935M | $-684M | $-536M | $-400M | $-363M | $-219M | $-251M | $-258M | $-160M | $-147M | $-101M | $-64M | |
| CapEx | $33M | $22M | $13M | $10M | $7M | $6M | $42M | $13M | $3M | $4M | $3M | $5M | |
| Investing Cash Flow | $-65M | $-583M | $-224M | $-35M | $-64M | $-7M | $-42M | $-15M | $-3M | $-4M | $-3M | · | |
| Stock Issued | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | $0 | $223M | $109M | |
| Net Stock Activity | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | · | $223M | · | |
| Financing Cash Flow | $954M | $1.34B | $168M | $793M | $613M | $271M | $285M | $387M | $381M | $31M | $228M | · | |
| Net Change in Cash | $-45M | $73M | $-592M | $357M | $184M | $45M | $-8M | $114M | $219M | $-120M | $124M | $45M | |
| Taxes Paid | $4M | $2M | $2M | $2M | $2M | $814.0K | $339.0K | $154.0K | $166.0K | $85.0K | $-3M | $9M | |
| Free Cash Flow | $-968M | $-706M | $-550M | $-410M | $-371M | $-226M | $-293M | $-271M | $-163M | $-151M | $-104M | · | |
| Levered FCF | $-1.05B | $-791M | $-632M | $-437M | $-411M | $-255M | $-321M | $-297M | $-169M | $-154M | $-107M | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 82.3% | · | · | · | · | · | |
| Operating Margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | · | · | · | · | |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | · | · | · | · | |
| Pretax Margin | -209.7% | -250.2% | -244.8% | -195.7% | -231.6% | -178.0% | -185.8% | -3295.1% | · | · | · | · | |
| EBITDA Margin | -205.6% | -241.5% | -230.7% | -184.2% | -194.2% | -155.8% | -168.6% | -3088.3% | · | · | · | · | |
| ROA | -59.5% | -54.5% | -50.2% | -33.2% | -42.6% | -38.2% | -37.8% | -60.8% | -55.0% | -59.3% | -40.2% | · | |
| ROE | -128.4% | -237.7% | 241.3% | -1660.7% | -95.0% | -92.9% | -89.9% | -129.8% | -74.7% | -75.6% | -47.5% | · | |
| ROIC | -97.8% | -63.5% | -86.5% | -37.8% | -38.2% | -42.1% | -39.5% | -58.6% | -45.3% | -82.9% | -34.3% | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 | 5.2 | 6.5 | 6.5 | 8.7 | 6.0 | 12.9 | · | |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 | 4.6 | 5.9 | 6.3 | 8.5 | 5.8 | 12.7 | · | |
| Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| LT Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| Interest Coverage | -14.9 | -10.3 | -8.7 | -17.3 | -9.3 | -9.0 | -8.5 | -12.1 | -31.9 | -49.6 | -40.7 | · |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.8 | 0.8 | 1.0 | 1.4 | 0.7 | · | · | · | · | |
| Receivables Turnover | 6.3 | 7.8 | 8.6 | 9.1 | 9.2 | 9.2 | 11.0 | 3.6 | · | · | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 66.7% | 19.2% | 24.4% | 30.2% | 14.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.2% | 24.5% | 22.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | $12M | |
| Net Income TTM | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| Market Cap | $37.29B | $12.38B | $4.59B | $2.71B | $3.23B | $3.42B | $2.14B | $1.01B | $2.39B | $821M | $1.12B | · | |
| Enterprise Value | $36.40B | $12.05B | $4.96B | $2.69B | $3.08B | $3.24B | $1.99B | $836M | $2.06B | $713M | $864M | · | |
| P/E | -27.1 | -12.4 | -5.8 | -5.1 | -7.0 | -11.1 | -7.9 | · | · | · | · | · | |
| P/S | 61.5 | 34.1 | 15.0 | 11.0 | 17.2 | 20.8 | 15.7 | 103.1 | · | · | · | · | |
| P/B | 50.5 | 43.4 | -13.8 | 30.8 | 7.9 | 12.4 | 8.2 | 4.9 | 6.6 | 5.3 | 3.6 | · | |
| P / Tangible Book | 73.8 | 136.7 | · | · | 16.1 | 15.1 | · | · | · | · | · | · | |
| P / Cash Flow | -39.9 | -18.1 | -8.6 | -6.8 | -8.9 | -15.6 | -8.5 | -3.9 | -15.0 | -5.6 | -11.1 | · | |
| P / FCF | -38.5 | -17.5 | -8.3 | -6.6 | -8.7 | -15.2 | -7.3 | -3.7 | -14.7 | -5.4 | -10.8 | · | |
| EV / EBITDA | -29.2 | -13.7 | -7.0 | -5.9 | -8.4 | -12.7 | -8.7 | -2.8 | -11.1 | -4.2 | -7.5 | · | |
| EV / FCF | -37.6 | -17.1 | -9.0 | -6.5 | -8.3 | -14.4 | -6.8 | -3.1 | -12.7 | -4.7 | -8.3 | · | |
| EV / Revenue | 60.0 | 33.1 | 16.3 | 11.0 | 16.4 | 19.7 | 14.6 | 85.0 | · | · | · | · | |
| Earnings Yield | -3.7% | -8.1% | -17.2% | -19.6% | -14.2% | -9.0% | -12.6% | · | · | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $425M | $306M | $264M | $142M | $107M | $93M | $104M | $93M | $90M | $76M | $84M | $79M | $77M | $65M | $59M | $68M | |
| Cost of Revenue | $67M | $47M | $44M | $29M | $28M | $21M | $26M | $21M | $21M | $17M | $18M | $17M | $17M | $14M | $13M | $13M | |
| R&D Expense | $210M | $209M | $255M | $186M | $177M | $153M | $180M | $151M | $147M | $121M | $137M | $109M | $197M | $128M | $125M | $100M | |
| SG&A Expense | $247M | $247M | $212M | $186M | $155M | $148M | $143M | $119M | $107M | $93M | $90M | $91M | $84M | $80M | $73M | $76M | |
| Operating Expenses | $427M | $459M | $584M | $508M | $420M | $341M | $335M | $307M | $379M | $221M | $262M | $227M | $313M | $213M | $211M | $195M | |
| Operating Income | $-2M | $-153M | $-320M | $-366M | $-313M | $-248M | $-230M | $-213M | $-289M | $-146M | $-178M | $-148M | $-236M | $-148M | $-151M | $-128M | |
| Interest Expense | · | · | · | · | $21M | $22M | $22M | $21M | $21M | $21M | $21M | $20M | $21M | $20M | $16M | $3M | |
| Other Non-op | $-531.0K | $-736.0K | $-2M | $-603.0K | $453.0K | $132.0K | $-445.0K | $2M | $-269.0K | $-1M | $2M | $285.0K | $-488.0K | $-111.0K | $1M | $-2M | |
| Pretax Income | $-11M | $-162M | $-327M | $-369M | $-320M | $-256M | $-234M | $-220M | $-300M | $-157M | $-185M | $-158M | $-244M | $-159M | $-160M | $-131M | |
| Income Tax | $2M | $1M | $2M | $1M | $1M | $912.0K | $1M | $1M | $838.0K | $589.0K | $998.0K | $544.0K | $530.0K | $483.0K | $125.0K | $372.0K | |
| Net Income | $-13M | $-164M | $-328M | $-370M | $-322M | $-257M | $-236M | $-221M | $-301M | $-157M | $-186M | $-159M | $-245M | $-160M | $-160M | $-131M | |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| Shares (Basic) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| Shares (Diluted) | 217,352,000 | 215,468,000 | -382,907,000 | 211,759,000 | 189,302,000 | 180,860,000 | -312,836,000 | 173,721,000 | 154,702,000 | 148,456,000 | -276,374,000 | 142,899,000 | 137,553,000 | 136,355,000 | -236,285,000 | 120,789,000 | |
| EBITDA | $-2M | $-153M | · | $-366M | $-313M | $-248M | · | $-213M | $-289M | $-146M | · | $-148M | $-236M | $-148M | · | $-128M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $582M | $510M | $335M | $1.28B | $403M | $555M | $461M | $1.25B | $596M | · | $487M | $613M | $969M | · | $415M | |
| Short-term Investments | $616M | $641M | $920M | $1.35B | $572M | $796M | $879M | $1.01B | $0 | $0 | · | $299M | $305M | $30M | · | $99M | |
| Receivables | $215M | $179M | $141M | $65M | $55M | $48M | $52M | $42M | $40M | $37M | · | $36M | $31M | $31M | · | $27M | |
| Inventory | $142M | $133M | $132M | $121M | $108M | $101M | $99M | $98M | $90M | $83M | · | $78M | $77M | $71M | · | $66M | |
| Prepaid Expense | $116M | $78M | $91M | $66M | $62M | $55M | $37M | $41M | $41M | $43M | · | $27M | $26M | $29M | · | $25M | |
| Current Assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | $1.40B | $1.62B | $1.65B | $1.42B | $759M | · | $927M | $1.05B | $1.13B | · | $632M | |
| PP&E (Net) | $107M | $103M | $103M | $90M | $90M | $88M | $80M | $75M | $73M | $69M | · | $65M | $62M | $60M | · | $54M | |
| PP&E (Gross) | $174M | $166M | $164M | $147M | $145M | $141M | $130M | $124M | $120M | $115M | · | $108M | $104M | $100M | · | $92M | |
| Accum. Depreciation | $67M | $64M | $61M | $57M | $55M | $52M | $50M | $49M | $47M | $46M | · | $43M | $42M | $41M | · | $38M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | · | $136M | $136M | $136M | · | $136M | |
| Intangibles | $93M | $96M | $98M | $85M | $56M | $57M | $59M | $60M | $61M | $62M | $64M | $65M | $66M | $67M | · | $70M | |
| Total Assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Accounts Payable | $75M | $73M | $80M | $80M | $74M | $58M | $73M | $65M | $51M | $44M | · | $65M | $56M | $57M | · | $12M | |
| Current Liabilities | $439M | $361M | $469M | $417M | $312M | $239M | $298M | $259M | $524M | $421M | · | $197M | $204M | $188M | · | $138M | |
| Capital Leases | $8M | $10M | $12M | $8M | $8M | $8M | $9M | $10M | $12M | $14M | · | $13M | $13M | $15M | · | $17M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $6M | $5M | $499.0K | $3M | $3M | $3M | · | $6M | $11M | $10M | · | $11M | |
| Total Liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | $1.70B | $1.74B | $1.57B | $1.77B | $1.62B | · | $1.61B | $1.59B | $1.56B | · | $1.02B | |
| Long-term Debt | $547M | $547M | $547M | $547M | $547M | $1.12B | · | $972M | $1.19B | $1.18B | · | $1.17B | $1.17B | $1.16B | · | $800M | |
| Total Debt | $544M | $542M | · | $540M | $539M | $1.11B | · | $955M | $1.17B | $1.16B | · | $1.15B | $1.14B | $1.13B | · | $785M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $6.57B | $6.50B | $6.37B | $6.25B | $6.18B | $4.71B | $4.65B | $4.61B | $3.94B | $3.14B | · | $2.97B | $2.95B | $2.81B | · | $2.51B | |
| Retained Earnings | $-5.81B | $-5.80B | $-5.64B | $-5.31B | $-4.94B | $-4.62B | $-4.36B | $-4.12B | $-3.90B | $-3.60B | · | $-3.26B | $-3.10B | $-2.86B | · | $-2.54B | |
| AOCI | $-3M | $4.0K | $1M | $2M | $2M | $-902.0K | $-2M | $547.0K | $-3M | $-2M | · | $-2M | $-1M | $1M | · | $-1M | |
| Stockholders' Equity | $757M | $705M | $739M | $946M | $1.25B | $99M | $285M | $483M | $39M | $-465M | $-332M | $-289M | $-156M | $-45M | $88M | $-30M | |
| Liabilities + Equity | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Shares Outstanding | 218,281,059 | 216,521,841 | 214,255,853 | 212,583,015 | 211,110,658 | 181,900,074 | 179,382,635 | 178,846,991 | 166,666,599 | 148,560,882 | 147,978,000 | 143,049,197 | 142,750,463 | 136,429,216 | 135,654,000 | 121,726,199 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $46M | $39M | $31M | $43M | $39M | $27M | $26M | $23M | $21M | $20M | $20M | $18M | $16M | $15M | $16M | |
| Deferred Tax | $0 | $0 | $-27.0K | $0 | $0 | $0 | $-29.0K | $0 | $0 | $0 | $-54.0K | $0 | $0 | $0 | $-231.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-89M | $-223M | $-248M | $-220M | $-206M | $-262M | $-196M | $-181M | $-123M | $-184M | $-131M | $-136M | $-123M | $-146M | $-103M | $-90M | |
| CapEx | $6M | $3M | $17M | $2M | $3M | $10M | $7M | $4M | $7M | $5M | $2M | $3M | $5M | $3M | $5M | $582.0K | |
| Investing Cash Flow | $25M | $266M | $389M | $-762M | $228M | $80M | $132M | $-1.00B | $-7M | $295M | $2M | $7M | $-274M | $42M | $20M | $49M | |
| Stock Issued | · | · | $0 | $-256.0K | · | · | $-12.0K | $371M | · | · | $114M | $0 | · | · | $259M | $33M | |
| Financing Cash Flow | $27M | $30M | $34M | $33M | $858M | $29M | $159M | $397M | $781M | $3M | $123M | $1M | $44M | $-399.0K | $743M | $37M | |
| Net Change in Cash | $-37M | $72M | $176M | $-950M | $881M | $-152M | $94M | $-785M | $651M | $113M | $-5M | $-126M | $-356M | $-105M | $659M | $-1M | |
| Taxes Paid | $696.0K | $3M | $111.0K | $1M | $677.0K | $2M | $248.0K | $689.0K | $354.0K | $1M | $75.0K | $518.0K | $358.0K | $1M | $91.0K | $432.0K | |
| Free Cash Flow | · | $-226M | · | · | · | $-272M | · | · | · | $-189M | · | · | · | $-150M | · | · | |
| Levered FCF | · | · | · | · | · | $-294M | · | · | · | $-210M | · | · | · | $-170M | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| Net Margin | -3.1% | -53.5% | · | -259.9% | -299.5% | -276.4% | · | -236.0% | -332.8% | -208.1% | · | -201.0% | -317.0% | -245.0% | · | -193.6% | |
| Pretax Margin | -2.7% | -53.0% | · | -259.0% | -298.3% | -275.4% | · | -235.0% | -331.8% | -207.3% | · | -200.3% | -316.3% | -244.2% | · | -193.1% | |
| EBITDA Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| ROA | -0.58% | -8.4% | · | -16.8% | -15.0% | -17.3% | · | -13.1% | -18.5% | -11.7% | · | -13.7% | -19.6% | -12.0% | · | -11.4% | |
| ROE | -1.3% | -40.7% | · | -51.8% | -49.9% | 140.3% | · | -227.3% | 514.2% | 61.7% | · | 99.6% | 439.1% | -424.7% | · | -55.2% | |
| ROIC | -0.14% | -12.4% | · | -24.7% | -17.6% | -20.7% | · | -14.9% | -23.9% | -20.9% | · | -17.3% | -24.0% | -13.7% | · | -17.0% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.5 | · | 4.6 | 6.7 | 5.9 | · | 6.4 | 2.7 | 1.8 | · | 4.7 | 5.2 | 6.0 | · | 4.6 | |
| Quick Ratio | 3.1 | 3.9 | · | 4.2 | 6.1 | 5.2 | · | 5.8 | 2.5 | 1.5 | · | 4.2 | 4.6 | 5.5 | · | 3.9 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 30.2 | -2.5 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 24.4 | -2.0 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| Interest Coverage | · | · | · | · | -14.7 | -11.5 | · | -10.1 | -13.6 | -6.9 | · | -7.3 | -11.4 | -7.4 | · | -38.1 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 3.1 | 2.7 | · | 2.6 | 2.3 | 2.2 | · | 2.4 | 2.5 | 2.2 | · | 2.5 | 2.6 | 2.3 | · | 2.9 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $981M | $649M | · | $436M | $384M | $352M | · | $338M | $322M | $297M | · | $289M | $275M | $251M | · | $233M | |
| Net Income TTM | $-869M | $-1.11B | · | $-1.17B | $-1.10B | $-935M | · | $-837M | $-861M | $-721M | · | $-695M | $-631M | $-481M | · | $-434M | |
| Market Cap | $23.27B | $35.41B | · | $30.61B | $21.25B | $13.88B | · | $13.06B | $11.17B | $4.03B | · | $3.61B | $3.01B | $2.33B | · | $2.62B | |
| Enterprise Value | $22.66B | $34.72B | · | $29.47B | $19.93B | $13.78B | · | $12.54B | $11.09B | $4.60B | · | $3.97B | $3.23B | $2.46B | · | $2.89B | |
| P/E | -25.0 | -29.0 | · | -23.5 | -15.9 | -13.4 | · | -13.6 | -11.4 | -5.3 | · | -4.9 | -4.4 | -4.4 | · | -5.9 | |
| P/S | 23.7 | 54.6 | · | 70.2 | 55.3 | 39.4 | · | 38.6 | 34.7 | 13.6 | · | 12.5 | 10.9 | 9.3 | · | 11.3 | |
| P/B | 30.7 | 50.2 | · | 32.4 | 17.0 | 139.9 | · | 27.0 | 287.7 | -8.7 | · | -12.5 | -19.3 | -52.1 | · | -87.5 | |
| P / Tangible Book | 44.1 | 74.8 | · | 42.2 | 20.1 | · | · | 45.4 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -159.0 | · | · | · | -52.9 | · | · | · | -21.9 | · | · | · | -15.9 | · | · | |
| P / FCF | · | -156.5 | · | · | · | -51.0 | · | · | · | -21.4 | · | · | · | -15.5 | · | · | |
| EV / EBITDA | -14635.9 | -226.5 | · | -80.5 | -63.7 | -55.5 | · | -58.8 | -38.4 | -31.6 | · | -26.9 | -13.7 | -16.6 | · | -22.7 | |
| EV / FCF | · | -153.5 | · | · | · | -50.6 | · | · | · | -24.4 | · | · | · | -16.4 | · | · | |
| EV / Revenue | 23.1 | 53.5 | · | 67.6 | 51.9 | 39.1 | · | 37.1 | 34.4 | 15.5 | · | 13.7 | 11.7 | 9.8 | · | 12.4 | |
| Earnings Yield | -4.0% | -3.4% | · | -4.3% | -6.3% | -7.5% | · | -7.4% | -8.8% | -18.9% | · | -20.4% | -22.9% | -22.6% | · | -17.0% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $606M | $364M | $305M | $245M | $188M |
| Marża Operacyjna % | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% |
| Zysk netto | $-1.28B | $-914M | $-750M | $-482M | $-435M |
| Rozwodniony EPS | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 |
| Wskaźnik bieżący | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 |
| Wskaźnik Szybkości | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-968M | $-706M | $-550M | $-410M | $-371M |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
- Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
- Presja konkurencyjna skłania Truist do obniżenia celu dla Insmed (INSM)
- Dyrektor generalny Insmed ujawnia, że populacja pacjentów w Japonii przekracza rynek amerykański w przypadku chorób płuc.
- Artisan Small Cap Fund sprzedał Insmed (INSM) w oparciu o rozważania dotyczące wyceny.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 753 emitenci · $16.3B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 137 (+28 vs poprzedni kw.) | 113 (+21 vs poprzedni kw.) | 248 (-30 vs poprzedni kw.) | 231 (+3 vs poprzedni kw.) | +38.4M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| FMR LLC | $1 246 915 143 | 11 694 946 | 7,63% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 109 696 908 | 10 407 962 | 6,79% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 043 902 026 | 9 790 865 | 6,38% | Akcje |
| BAKER BROS. ADVISORS LP | $937 841 355 | 8 796 111 | 5,74% | Akcje |
| Capital International Investors | $878 338 960 | 8 238 124 | 5,37% | Akcje |
| Darwin Global Management, Ltd. | $673 600 013 | 6 431 163 | 4,12% | Akcje |
| STATE STREET CORP | $645 282 792 | 6 052 174 | 3,95% | Akcje |
| Artisan Partners Limited Partnership | $580 195 955 | 5 441 718 | 3,55% | Akcje |
| RTW INVESTMENTS, LP | $516 347 866 | 4 842 880 | 3,16% | Akcje |
| AMERIPRISE FINANCIAL INC | $483 856 150 | 4 538 102 | 2,96% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $389 229 811 | 3 661 786 | 2,38% | Akcje |
| NORGES BANK | $360 124 083 | 3 377 641 | 2,20% | Akcje |
| MAVERICK CAPITAL LTD | $229 314 244 | 2 150 762 | 1,40% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $218 358 293 | 2 048 005 | 1,34% | Akcje |
| Qube Research & Technologies Ltd | $179 370 451 | 1 682 334 | 1,10% | Akcje |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $173 743 795 | 1 629 561 | 1,06% | Akcje |
| Integral Health Asset Management, LLC | $170 592 000 | 1 600 000 | 1,04% | Akcje |
| CITADEL ADVISORS LLC | $160 586 566 | 1 506 158 | 0,98% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $149 433 474 | 1 401 552 | 0,91% | Akcje |
| Balyasny Asset Management L.P. | $141 423 967 | 1 326 430 | 0,86% | Akcje |
| Paradigm Biocapital Advisors LP | $141 375 668 | 1 325 977 | 0,86% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $132 445 710 | 1 242 222 | 0,81% | Akcje |
| Pictet Asset Management Holding SA | $129 804 038 | 1 220 353 | 0,79% | Akcje |
| D. E. Shaw & Co., Inc. | $120 259 044 | 1 127 922 | 0,74% | Akcje |
| Hood River Capital Management LLC | $112 683 586 | 1 056 871 | 0,69% | Akcje |
| Castle Hook Partners LP | $105 906 712 | 993 310 | 0,65% | Akcje |
| JENNISON ASSOCIATES LLC | $96 501 143 | 905 094 | 0,59% | Akcje |
| TimesSquare Capital Management, LLC | $95 626 169 | 584 798 | 0,58% | Akcje |
| Polar Capital Holdings Plc | $94 984 773 | 890 872 | 0,58% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $92 119 680 | 864 000 | 0,56% | Opcja kupna |
| FIL Ltd | $91 289 537 | 856 214 | 0,56% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $91 280 154 | 856 126 | 0,56% | Akcje |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $90 627 000 | 850 000 | 0,55% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84 788 663 | 795 242 | 0,52% | Akcje |
| GOLDMAN SACHS GROUP INC | $81 873 498 | 767 900 | 0,50% | Opcja sprzedaży |
| AMERICAN CENTURY COMPANIES INC | $81 002 980 | 759 735 | 0,50% | Akcje |
| Caption Management, LLC | $78 973 434 | 740 700 | 0,48% | Opcja sprzedaży |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $77 763 723 | 729 354 | 0,48% | Akcje |
| GOLDMAN SACHS GROUP INC | $77 305 085 | 725 052 | 0,47% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76 670 442 | 719 100 | 0,47% | Opcja sprzedaży |
| Clearbridge Investments, LLC | $76 331 581 | 715 922 | 0,47% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76 297 272 | 715 600 | 0,47% | Opcja kupna |
| ALLIANCEBERNSTEIN L.P. | $75 676 402 | 462 796 | 0,46% | Akcje |
| Ensign Peak Advisors, Inc | $74 948 636 | 702 951 | 0,46% | Akcje |
| Affinity Asset Advisors, LLC | $69 303 000 | 650 000 | 0,42% | Akcje |
| TWO SIGMA ADVISERS, LP | $68 745 800 | 395 000 | 0,42% | Akcje |
| Caption Management, LLC | $67 170 600 | 630 000 | 0,41% | Opcja kupna |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $67 152 581 | 629 831 | 0,41% | Akcje |
| Squarepoint Ops LLC | $65 727 392 | 616 464 | 0,40% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $65 302 719 | 612 596 | 0,40% | Akcje |
| Railway Pension Investments Ltd | $64 473 114 | 604 700 | 0,39% | Akcje |
| Swiss National Bank | $63 280 249 | 593 512 | 0,39% | Akcje |
| Artia Global Partners LP | $62 804 724 | 589 052 | 0,38% | Akcje |
| EVENTIDE ASSET MANAGEMENT, LLC | $62 220 874 | 583 665 | 0,38% | Akcje |
| Davern Capital Partners, LP | $59 688 435 | 559 824 | 0,37% | Akcje |
| Candriam S.C.A. | $59 131 121 | 555 131 | 0,36% | Akcje |
| Point72 Asset Management, L.P. | $57 254 620 | 536 997 | 0,35% | Akcje |
| Long Focus Capital Management, LLC | $56 295 360 | 528 000 | 0,34% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49 576 321 | 303 182 | 0,30% | Akcje |
| BlackRock, Inc. | $49 204 384 | 461 493 | 0,30% | Akcje |
| Bridgewater Associates, LP | $48 553 895 | 455 392 | 0,30% | Akcje |
| JANE STREET GROUP, LLC | $48 160 254 | 451 700 | 0,29% | Opcja kupna |
| WELLINGTON MANAGEMENT GROUP LLP | $47 494 625 | 445 457 | 0,29% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $46 668 960 | 437 713 | 0,29% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $44 365 435 | 416 108 | 0,27% | Akcje |
| Palo Alto Investors LP | $44 138 548 | 413 980 | 0,27% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $42 729 564 | 400 765 | 0,26% | Akcje |
| Eagle Health Investments LP | $40 955 941 | 384 130 | 0,25% | Akcje |
| Prosight Management, LP | $40 047 432 | 375 609 | 0,24% | Akcje |
| GATEWAY INVESTMENT ADVISERS LLC | $38 916 300 | 365 000 | 0,24% | Akcje |
| Rock Springs Capital Management LP | $38 612 433 | 362 150 | 0,24% | Akcje |
| CITADEL ADVISORS LLC | $38 084 664 | 357 200 | 0,23% | Opcja kupna |
| NEUBERGER BERMAN GROUP LLC | $37 086 246 | 347 836 | 0,23% | Akcje |
| JANE STREET GROUP, LLC | $36 975 816 | 346 800 | 0,23% | Opcja sprzedaży |
| ENVESTNET ASSET MANAGEMENT INC | $35 930 149 | 336 997 | 0,22% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $34 817 934 | 326 561 | 0,21% | Akcje |
| BANK OF AMERICA CORP /DE/ | $33 116 173 | 310 600 | 0,20% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $33 084 186 | 310 300 | 0,20% | Opcja kupna |
| VICTORY CAPITAL MANAGEMENT INC | $32 695 129 | 306 651 | 0,20% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $32 437 642 | 304 236 | 0,20% | Akcje |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $31 622 852 | 296 594 | 0,19% | Akcje |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30 876 512 | 289 594 | 0,19% | Akcje |
| Defilade Capital Management, L.P. | $30 049 568 | 281 838 | 0,18% | Akcje |
| SAMLYN CAPITAL, LLC | $29 812 765 | 279 617 | 0,18% | Akcje |
| CITADEL ADVISORS LLC | $29 181 894 | 273 700 | 0,18% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $29 076 813 | 272 715 | 0,18% | Akcje |
| First Turn Management, LLC | $28 131 794 | 263 851 | 0,17% | Akcje |
| Bank of New York Mellon Corp | $27 412 962 | 257 109 | 0,17% | Akcje |
| California Public Employees Retirement System | $26 692 317 | 250 350 | 0,16% | Akcje |
| Vestal Point Capital, LP | $26 655 000 | 250 000 | 0,16% | Akcje |
| Fiera Capital Corp | $26 535 159 | 248 876 | 0,16% | Akcje |
| TD Asset Management Inc | $25 608 205 | 240 182 | 0,16% | Akcje |
| Caption Management, LLC | $25 162 320 | 236 000 | 0,15% | Akcje |
| Trails Edge Capital Partners, LP | $24 557 891 | 230 331 | 0,15% | Akcje |
| ADAR1 Capital Management, LLC | $24 364 802 | 228 520 | 0,15% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $23 363 000 | 219 123 | 0,14% | Akcje |
| Assenagon Asset Management S.A. | $23 271 947 | 218 270 | 0,14% | Akcje |
| DNB Asset Management AS | $22 737 675 | 213 259 | 0,14% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $22 675 515 | 212 676 | 0,14% | Akcje |
| Longaeva Partners L.P. | $21 454 716 | 201 226 | 0,13% | Akcje |
Insiderzy spółki 48 insiderów · 29 dyrektorzy generalni · 18 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 23 lipca 2026 M | 259 058 | 0 | 67 | $-31 886 073 |
| Timothy Whitten | President & CEO | 1 czerwca 2012 P | 10 000 | 0 | 0 | $0 |
| Geoffrey Allan | President, CEO and Chairman | 31 marca 2009 M | 1 715 557 | 0 | 0 | $0 |
| Sara Bonstein | Chief Financial Officer | 3 czerwca 2026 S | 69 082 | 0 | 1 | $-245 857 |
| Paolo Tombesi | Chief Financial Officer | 3 stycznia 2019 A | 10 669 | 0 | 0 | $0 |
| Andrew T Drechsler | Chief Financial Officer | 1 marca 2017 M | 15 000 | 0 | 0 | $0 |
| Kevin P Tully | Executive VP & CFO | 21 grudnia 2011 A | 377 344 | 0 | 0 | $0 |
| Steve C Glover | President Follow-on Biologics | 31 marca 2009 M | 372 113 | 0 | 0 | $0 |
| Ronald D Gunn | Executive Vice President & COO | 8 grudnia 2005 A | 40 074 | 0 | 0 | $0 |
| Samuele Butera | SVP, GM, Global Respiratory | 23 czerwca 2026 A | 7 342 | 0 | 0 | $0 |
| Michael Alexander Smith | Chief Legal Officer | 22 czerwca 2026 S | 37 648 | 0 | 2 | $-393 852 |
| Orlov S Nicole Schaeffer | Chief People Strategy Officer | 2 stycznia 2026 M | 41 754 | 0 | 9 | $-26 423 350 |
| John Drayton Wise | Chief Commercial Officer | 23 maja 2022 A | 78 137 | 0 | 0 | $0 |
| John Soriano | Chief Compliance Officer | 7 września 2021 M | 35 204 | 0 | 0 | $0 |
| Christine A Pellizzari | Chief Legal Officer | 15 maja 2021 F | 149 985 | 0 | 0 | $0 |
| John Goll | Chief Accounting Officer | 3 stycznia 2020 A | 14 166 | 0 | 0 | $0 |
| Paul Streck | Chief Medical Officer | 8 sierpnia 2018 A | 15 996 | 0 | 0 | $0 |
| Eugene Jeffrey Sullivan | Chief Med. & Scientific Ofc. | 17 maja 2017 A | — | 0 | 0 | $0 |
| Mark Quigley | Vice President, Quality | 12 maja 2015 M | 0 | 0 | 0 | $0 |
| Peggy Berry | Vice President, Regulatory | 26 lutego 2015 A | — | 0 | 0 | $0 |
| Matthew Pauls | Chief Commercial Officer | 2 czerwca 2014 A | — | 0 | 0 | $0 |
| Andrea Holtzman Drucker | SVP, Gen. Counsel & Corp Sec. | 3 czerwca 2013 M | 45 000 | 0 | 0 | $0 |
| Renu Gupta | EVP & Chief Medical Officer | 23 maja 2013 A | 19 507 | 0 | 0 | $0 |
| Nicholas A. Labella Jr. | Chief Scientific Officer | 21 grudnia 2011 A | — | 0 | 0 | $0 |
| Nicholas Lee Gurreri | Senior VP, Commercial Ops | 31 stycznia 2011 A | — | 0 | 0 | $0 |
| Doug Farrar | Vice President, ITP | 31 marca 2009 M | 292 055 | 0 | 0 | $0 |
| Michael Duncan | Principal Financial Officer | 8 grudnia 2005 A | — | 0 | 0 | $0 |
| Philip J Young | Chief Business Officer and EVP | 8 grudnia 2005 A | — | 0 | 0 | $0 |
| Thomas A Keuer | Sr VP, ITP (Subsidiary) | 8 grudnia 2005 A | — | 0 | 0 | $0 |
| Melvin Sharoky MD | Dyrektor | 13 maja 2026 A | 246 081 | 0 | 3 | $-6 849 100 |
| David W J Mcgirr | Dyrektor | 9 lutego 2026 G | 53 400 | 0 | 0 | $0 |
| Clarissa Desjardins | Dyrektor | 11 maja 2022 A | 35 595 | 0 | 0 | $0 |
| Elizabeth M Anderson | Dyrektor | 11 maja 2022 A | 42 317 | 0 | 0 | $0 |
| Leo Lee | Dyrektor | 11 maja 2022 A | 53 265 | 0 | 0 | $0 |
| David R Brennan | Dyrektor | 11 maja 2022 A | 95 521 | 0 | 0 | $0 |
| Alfred Altomari | Dyrektor | 11 maja 2022 A | 43 141 | 0 | 0 | $0 |
| Steinar J Engelsen | Dyrektor | 1 listopada 2021 P | 320 802 | 0 | 0 | $0 |
| Donald J Hayden JR | Dyrektor | 9 kwietnia 2019 M | 62 197 | 0 | 0 | $0 |
| Myrtle S Potter | Dyrektor | 15 maja 2018 A | 25 510 | 0 | 0 | $0 |
| Randall W Whitcomb | Dyrektor | 10 marca 2015 M | 69 188 | 0 | 0 | $0 |
| Richard S Kollender | Dyrektor | 31 października 2013 M | 24 598 | 0 | 0 | $0 |
| Dennis M Lanfear | Dyrektor | 9 czerwca 2010 A | 168 404 | 0 | 0 | $0 |
| Graham K Crooke | Dyrektor | 9 czerwca 2010 A | 228 404 | 0 | 0 | $0 |
| Kenneth G Condon | Dyrektor | 9 czerwca 2010 A | 168 504 | 0 | 0 | $0 |
| FMR LLC | Posiadacz 10% | 22 lipca 2013 S | 2 221 | 0 | 0 | $0 |
| Roger Adsett | — | 10 sierpnia 2026 M | 98 744 | 0 | 2 | $-32 207 190 |
| Martina Flammer M.D. | — | 6 sierpnia 2026 M | 60 486 | 0 | 5 | $-5 110 195 |
| Carol Schafer | — | 13 maja 2026 A | 66 622 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 121 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 3,71% | 7 509 NS | 30 kwietnia 2026 | N-PORT |
| IBB · iShares Trust | 2,19% | 1 576 476 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,94% | 11 797 SH | 8 sierpnia 2026 | Dziennie |
| FMED · Fidelity Covington Trust | 1,79% | 6 875 NS | 31 maja 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,70% | 15 835 NS | 31 maja 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,44% | 92 576 NS | 30 kwietnia 2026 | N-PORT |
| BIB · ProShares Trust | 1,16% | 7 968 NS | 31 maja 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,11% | 2 081 NS | 31 maja 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,10% | 4 801 NS | 30 kwietnia 2026 | N-PORT |
| SPIT · RBB Fund, Inc. | 1,06% | 2 228 NS | 30 kwietnia 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,92% | 34 830 NS | 30 kwietnia 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0,90% | 80 500 NS | 30 kwietnia 2026 | N-PORT |
| IWP · iShares Trust | 0,81% | 1 239 854 SH | 8 sierpnia 2026 | Dziennie |
| HRTS · Tema ETF Trust | 0,71% | 3 449 NS | 31 maja 2026 | N-PORT |
| LFSC · RBB Fund, Inc. | 0,62% | 6 050 NS | 31 maja 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,58% | 35 661 NS | 30 kwietnia 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0,50% | 40 138 NS | 30 kwietnia 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,47% | 98 313 NS | 30 kwietnia 2026 | N-PORT |
| IYH · iShares Trust | 0,46% | 128 330 SH | 8 sierpnia 2026 | Dziennie |
| FFSM · FIDELITY COVINGTON TRUST | 0,40% | 37 505 NS | 30 kwietnia 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,39% | 36 063 NS | 30 kwietnia 2026 | N-PORT |
| SMLF · iShares Trust | 0,39% | 123 385 SH | 8 sierpnia 2026 | Dziennie |
| IMCG · iShares Trust | 0,38% | 116 453 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,33% | 632 581 SH | 8 sierpnia 2026 | Dziennie |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 1 435 651 SH | 8 sierpnia 2026 | Dziennie |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,30% | 695 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,26% | 2 487 127 SH | 8 sierpnia 2026 | Dziennie |
| VOT · VANGUARD INDEX FUNDS | 0,25% | 830 249 SH | 8 sierpnia 2026 | Dziennie |
| FDG · AMERICAN CENTURY ETF TRUST | 0,24% | 9 338 NS | 31 maja 2026 | N-PORT |
| SIZE · iShares Trust | 0,23% | 7 501 SH | 8 sierpnia 2026 | Dziennie |
| FFLG · FIDELITY COVINGTON TRUST | 0,22% | 9 640 NS | 30 kwietnia 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,22% | 31 591 SH | 8 sierpnia 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,21% | 22 539 NS | 30 kwietnia 2026 | N-PORT |
| ESLV · Strategy Shares | 0,20% | 176 NS | 30 kwietnia 2026 | N-PORT |
| IWR · iShares Trust | 0,20% | 873 374 SH | 8 sierpnia 2026 | Dziennie |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 32 329 NS | 30 kwietnia 2026 | N-PORT |
| ESLG · Strategy Shares | 0,20% | 279 NS | 30 kwietnia 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,19% | 6 824 NS | 30 kwietnia 2026 | N-PORT |
| IMCB · iShares Trust | 0,19% | 24 582 SH | 8 sierpnia 2026 | Dziennie |
| ESUM · Strategy Shares | 0,19% | 2 146 NS | 30 kwietnia 2026 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0,17% | 3 643 NS | 30 kwietnia 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,16% | 155 NS | 31 maja 2026 | N-PORT |
| QYLD · Global X Funds | 0,16% | 98 226 NS | 30 kwietnia 2026 | N-PORT |
| QCLR · Global X Funds | 0,15% | 45 NS | 30 kwietnia 2026 | N-PORT |
| QYLG · Global X Funds | 0,15% | 1 572 NS | 30 kwietnia 2026 | N-PORT |
| QTR · Global X Funds | 0,15% | 32 NS | 30 kwietnia 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,15% | 24 910 NS | 31 maja 2026 | N-PORT |
| QRMI · Global X Funds | 0,15% | 174 NS | 30 kwietnia 2026 | N-PORT |
| PTNQ · Pacer Funds Trust | 0,14% | 13 104 NS | 30 kwietnia 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 2 485 842 SH | 8 sierpnia 2026 | Dziennie |